19 June 2025
Ropes & Gray Represents Sanofi and EQT Life Sciences in Investment in SpliceBio’s $135 Million Series B Financing
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Dowling | Ropes & Gray | Counsel | venture capital and emerging companies | Not stated |
| Melissa Rones | Ropes & Gray | Partner | IP transactions | Not stated |
| Ryan Murphey | Ropes & Gray | Counsel | IP transactions | Not stated |
| Jennifer Eppinger | Ropes & Gray | Associate | strategic transactions | Not stated |
| Rajarshi Banerjee | Ropes & Gray | Partner | venture capital and emerging companies | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 135m ($135 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Sanofi (Investor)
EQT Life Sciences (Investor)
SpliceBio (Issuer)